FdaApplication
ANDA 217031
Identifiers
- fda_app_no: ANDA217031
Properties
| Property | Value |
|---|---|
| applicant_name | BIOCON PHARMA INC |
| application_type | ANDA |
| approval_date | 2023-11-29 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MYCOPHENOLATE SODIUM | MYCOPHENOLATE SODIUM | EQ 360MG BASE | TABLET, DELAYED RELEASE;ORAL |
| MYCOPHENOLATE SODIUM | MYCOPHENOLATE SODIUM | EQ 180MG BASE | TABLET, DELAYED RELEASE;ORAL |
2 products